15 Jan 2015 07:00
Ark Therapeutics Group plc
Transfer of listing category on the Official List
London, UK, 15 January 2015 (LSE: AKT): Ark Therapeutics Group plc ("Ark" or the "Company") announces that, following the passing of the relevant resolution by its shareholders at the Company's General Meeting on 11 December 2014, the Company's listing category will be transferred from "premium listing (commercial company)" to "standard listing" as of 8.00 am today. The Company's ordinary shares will remain suspended pending the publication of a prospectus in relation to the proposed acquisition of Premier Veterinary Group Limited, which constitutes a reverse takeover.
For further information please contact:
Ark Therapeutics Group plc | Tel: +44(0)203 755 5160 |
Iain G Ross, Non-Executive Chairman
Susan Steven, Non-Executive Director
This announcement includes "forward-looking statements" which include all statements other than statements of historical facts, including, without limitation, those regarding Ark's financial position, business strategy, plans and objectives of management for future operations, and any statements preceded by, followed by or that include forward-looking terminology such as the words "targets", "believes", "estimates", "expects", "aims", "intends", "will", "can", "may", "anticipates", "would", "should", "could" or similar expressions or the negative thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond Ark's control that could cause the actual results, performance or achievements of Ark to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding Ark's present and future business strategies and the environment in which Ark will operate in the future. These forward-looking statements speak only as at the date of this announcement. Ark expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this announcement to reflect any change in Ark's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based. As a result of these factors, readers are cautioned not to rely on any forward-looking statement.